# Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer

> **NCT03579394** · NA · COMPLETED · sponsor: **ARCAGY/ GINECO GROUP** · enrollment: 211 (actual)

## Conditions studied

- Ovarian Cancer Stage IV
- Ovarian Cancer Stage IIIC
- Ovarian Cancer Stage IIIb

## Interventions

- **PROCEDURE:** Retarded IDS (Interval Debulking Surgery)
- **PROCEDURE:** Standard IDS (Interval Debulking Surgery)

## Key facts

- **NCT ID:** NCT03579394
- **Lead sponsor:** ARCAGY/ GINECO GROUP
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-19
- **Primary completion:** 2025-10-17
- **Final completion:** 2025-10-17
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579394, "Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03579394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*